Correlation Between DMK Pharmaceuticals and OKYO Pharma
Can any of the company-specific risk be diversified away by investing in both DMK Pharmaceuticals and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DMK Pharmaceuticals and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DMK Pharmaceuticals and OKYO Pharma Ltd, you can compare the effects of market volatilities on DMK Pharmaceuticals and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DMK Pharmaceuticals with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DMK Pharmaceuticals and OKYO Pharma.
Diversification Opportunities for DMK Pharmaceuticals and OKYO Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between DMK and OKYO is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding DMK Pharmaceuticals and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and DMK Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DMK Pharmaceuticals are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of DMK Pharmaceuticals i.e., DMK Pharmaceuticals and OKYO Pharma go up and down completely randomly.
Pair Corralation between DMK Pharmaceuticals and OKYO Pharma
If you would invest 148.00 in OKYO Pharma Ltd on May 5, 2025 and sell it today you would earn a total of 162.00 from holding OKYO Pharma Ltd or generate 109.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
DMK Pharmaceuticals vs. OKYO Pharma Ltd
Performance |
Timeline |
DMK Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
OKYO Pharma |
DMK Pharmaceuticals and OKYO Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DMK Pharmaceuticals and OKYO Pharma
The main advantage of trading using opposite DMK Pharmaceuticals and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DMK Pharmaceuticals position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.DMK Pharmaceuticals vs. Alto Neuroscience, | DMK Pharmaceuticals vs. Regeneron Pharmaceuticals | DMK Pharmaceuticals vs. Molecular Partners AG | DMK Pharmaceuticals vs. Definitive Healthcare Corp |
OKYO Pharma vs. Cardio Diagnostics Holdings | OKYO Pharma vs. Heart Test Laboratories | OKYO Pharma vs. Scisparc | OKYO Pharma vs. Sharps Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |